SCHEMBL5085504

SCHEMBL5085504

Cc1cc(Nc2ccccc2)nc2c(F)c(-c3cn4c(C5CC(O)C5)ncc4c(N)n3)ccc12

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 8/20 0.34
ABL1 P00519 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
PDGFRB P09619 1/20 0.31
PDGFRA P16234 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5083455 0.88 DHFR (0.34) IGF1R
SCHEMBL5085520 0.84 IGF1R (0.40) IGF1R
SCHEMBL400050 0.78 IGF1R (0.54) IGF1R
SCHEMBL5082570 0.75 TNK2 (0.39) IGF1R
SCHEMBL5083298 0.72 IGF1R (0.40) IGF1RMEN1KMT2A
SCHEMBL4356352 0.67 GSK3B (0.41) IGF1RABL1
SCHEMBL5083797 0.66 IGF1R (0.38) IGF1R
SCHEMBL402030 0.66 IGF1R (0.68) IGF1R
SCHEMBL399465 0.65 IGF1R (0.57) IGF1R
SCHEMBL5085414 0.64 TNK2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979002-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI Pharmaceuticals, Inc. (US) 2008-10-15 EP disclosed
WO-2007075554-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2007-07-05 WO disclosed